Quitbot Program for Smoking Cessation
Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 3
Waitlist Available
Sponsor: Fred Hutchinson Cancer Research Center
No Placebo Group
Pivotal Trial (Near Approval)
Prior Safety Data
Trial Summary
What is the purpose of this trial?This phase III trial compares two remote digital smoking cessation programs to see how well they work for quitting smoking.
Eligibility Criteria
This trial is for smokers who have smoked at least one cigarette daily for the past year, want to quit within a month, and are willing to try a digital program. They must live in the US, read English, not use other cessation methods, be open to random assignment to either program, and have daily access to a smartphone with text messaging and Facebook Messenger.Inclusion Criteria
Has at least daily access to their own smartphone
Not using other smoking cessation interventions (This eligibility requirement helps ensure results are due to the treatments we recommend rather than those that participants are doing on their own.)
I am 18 years old or older.
+8 more
Exclusion Criteria
I do not meet the specific requirements listed for the trial.
Participant Groups
The study compares two remote digital smoking cessation programs. Participants will receive support through their smartphones using either an experimental or control program designed to help them stop smoking.
2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (QuitBot Experimental)Experimental Treatment1 Intervention
Participants participate in the Quitbot program for 42 days to support quitting smoking. Therapy description withheld to protect the integrity of the study.
Group II: Group II (QuitBot Control)Active Control1 Intervention
Participants participate in the Quitbot program for 42 days to support quitting smoking. Therapy description withheld to protect the integrity of the study.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Fred Hutch/University of Washington Cancer ConsortiumSeattle, WA
Loading ...
Who Is Running the Clinical Trial?
Fred Hutchinson Cancer Research CenterLead Sponsor
Fred Hutchinson Cancer CenterLead Sponsor
National Cancer Institute (NCI)Collaborator